Specifically, in the present study, we established causality by inhibiting the action of the CLOCK/BMAL1 complex, having observed that leukocyte–endothelial interactions were enhanced in a similar way to that seen in type 2 diabetes participants. Here, BMAL1 is linked to type 2 diabetes mellitus.